Corvus Pharmaceuticals CRVS
NASDAQ CRVS
$11.76 -0.11 (-0.93%)
At close: Sep 29, 2026 · 4:00 PM EDT

Corvus Pharmaceuticals (CRVS) Enterprise Value (2016 - 2026)

Updated

Corvus Pharmaceuticals (CRVS) recorded Enterprise Value of $1.04 billion in Q2 2026, up 267.6% from $283.37 million a year earlier and up 4.8% from the prior quarter.

Analysis

Corvus Pharmaceuticals (CRVS) Enterprise Value (2016 - 2026) Analysis & Trends

On a TTM basis, Corvus Pharmaceuticals' Enterprise Value came in at $745.21 million as of Jun 30, 2026, up 236.1% year-over-year; for FY2025, it was $518.41 million, up 66.5% from FY2024.

  • Annual Enterprise Value has increased for three straight years, with a five-year compound annual growth rate of 43.7% (FY2020 to FY2025).
  • Across earlier years, Enterprise Value came in at $311.3 million in FY2024 (+322.5%), $73.69 million in FY2023 (+179.0%), $26.41 million in FY2022 (-45.8%) and $48.74 million in FY2021 (-42.4%).
  • The Q2 2026 figure is the highest quarterly Enterprise Value in data going back to Q1 2016.
  • On a year-over-year basis, Enterprise Value has increased for eight consecutive quarters, with growth averaging 247.2% over the last eight quarters.
  • Peak year-over-year performance for Enterprise Value in the last five years was growth of 532.6% in Q3 2024, against a decline of 91.1% in Q3 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $993.53 million (Q1 2026), $518.41 million (Q4 2025) and $547.54 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Corvus Pharmaceuticals 998.52 Mn 486.96 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.04 Bn
Mar 31, 2026 993.53 Mn
Dec 31, 2025 518.41 Mn
Sep 30, 2025 547.54 Mn
Jun 30, 2025 283.37 Mn
Mar 31, 2025 211.78 Mn
Dec 31, 2024 311.30 Mn
Sep 30, 2024 325.74 Mn
Jun 30, 2024 99.00 Mn
Mar 31, 2024 79.83 Mn
Dec 31, 2023 73.69 Mn
Sep 30, 2023 51.49 Mn
Jun 30, 2023 104.32 Mn
Mar 31, 2023 32.72 Mn
Dec 31, 2022 26.41 Mn
Sep 30, 2022 13.59 Mn
Jun 30, 2022 17.61 Mn
Mar 31, 2022 44.89 Mn
Dec 31, 2021 48.74 Mn
Sep 30, 2021 152.99 Mn
API Access

Corvus Pharmaceuticals Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=CRVS&period=max&api_key=YOUR_API_KEY